Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 230

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial

Open access
Bermejo, Javier, Yotti, Raquel, García-Orta, Rocío, Sánchez-Fernández, Pedro L, Castaño, Mario, Segovia-Cubero, Javier, Escribano-Subías, Pilar, San Román, José Alberto, Borrás, Xavier, Alonso-Gómez, Angel, Botas, Javier, Crespo-Leiro, María G, Velasco, Sonia, Bayés-Genís, Antoni, López, Amador, Muñoz-Aguilera, Roberto, de Teresa, Eduardo, González-Juanatey, José R, Evangelista, Arturo, Mombiela, Teresa, González-Mansilla, Ana, Elízaga, Jaime, Martín-Moreiras, Javier, González-Santos, José M, Moreno-Escobar, Eduardo, Fernández-Avilés, Francisco, Sildenafil for Improving Outcomes after VAlvular Correction (SIOVAC) investigators, Bermejo, Javier, Yotti, Raquel, Mombiela, Teresa, Gónzález-Mansilla, Ana, Elízaga, Jaime, García-Robles, José A, Pérez-David, Esther, Pérez del Villar, Candelas, Sanz, Ricardo, Gutierrez-Ibanes, Enrique, Vázquez, María E, Mur, Ana, Benito, Yolanda, Martínez-Legazpi, Pablo, Barrio, Alicia, Vázquez, Alexandra, García-Orta, Rocío, Uribe, Inés, González, Mercedes, Luis Sánchez, Pedro, González-Santos, José M, Martín-Moreiras, Javier, Arribas, Antonio, Clemente Lorenzo, M Milagros, Diego Nieto, Alejandro, Castaño, Mario, Pérez de Prado, Armando, Alonso, David, Segovia-Cubero, Javier, Gómez-Bueno, Manuel, Sayago Silva, Inés, Ángel Cavero, Miguel, Escribano-Subias, Pilar, Domínguez, Laura, Tello de Meneses, Rocío, Ruiz Cano, M José, Jiménez López-Guarch, Carmen, San Román, J Alberto, Mota, Pedro, Borrás, Xavier, Amorós Galitó, Carmen, Alonso-Gómez, Angel, Belló Mora, M Concepción, Mesa Rubio, Dolores, Botas, Javier, Campuzano, Raquel, Crespo-Leiro, María G, Marzoa, Raquel, Cuenca, José, Velasco, Sonia, Muñoz, Roberto, Suberviola, Verónica, Beltrán Herrera, Cristina, Mora, Laura, Mar Sarrión, M, Vaqueriza, David, Bayes-Genís, Antoni, Ferrer, Elena, González-Juanatey, José R, Cid, Belén, Monzonís, Amparo Martínez, López, Amador, Arizón de Prado, José M, Santisteban, Marta, Mesa Rubio, Dolores, Evangelista, Arturo, García-Dorado, David, de Teresa, Eduardo, Jiménez-Navarro, Manuel, Carrasco Chinchilla, Fernando, Moreno-Escobar, Eduardo, Alonso, Joaquín · 2018 · European Heart Journal

Abstract

Aims: We aimed to determine whether treatment with sildenafil improves outcomes of patients with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD). Methods and results: The sildenafil for improving outcomes after valvular correction (SIOVAC) study was a multricentric, randomized, parallel, and placebo-controlled trial that enrolled stable adults with mean pulmonary artery pressure ≥ 30 mmHg who had undergone a successful valve replacement or repair procedure at least 1 year before inclusion. We assigned 200 patients to receive sildenafil (40 mg three times daily, n = 104) or placebo (n = 96) for 6 months. The primary endpoint was the composite clinical score combining death, hospital admission for heart failure (HF), change in functional class, and patient global self-assessment. Only 27 patients receiving sildenafil improved their composite clinical score, as compared with 44 patients receiving placebo; in contrast 33 patients in the sildenafil group worsened their composite score, as compared with 14 in the placebo group [odds ratio 0.39; 95% confidence interval (CI) 0.22-0.67; P < 0.001]. The Kaplan-Meier estimates for survival without admission due to HF were 0.76 and 0.86 in the sildenafil and placebo groups, respectively (hazard ratio 2.0, 95% CI = 1.0-4.0; log-rank P = 0.044). Changes in 6-min walk test distance, natriuretic peptides, and Doppler-derived systolic pulmonary pressure were similar in both groups. Conclusion: Treatment with sildenafil in patients with persistent PH after successfully corrected VHD is associated to worse clinical outcomes than placebo. Off-label usage of sildenafil for treating this source of left heart disease PH should be avoided. The trial is registered with ClinicalTrials.gov, number NCT00862043.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehx700

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 230

Metadata

Authors
Bermejo, J., Yotti, R., García-Orta, R., Sánchez-Fernández, P. L., Castaño, M., Segovia-Cubero, J., Escribano-Subías, P., San Román, J. A., Borrás, X., Alonso-Gómez, A., Botas, J., Crespo-Leiro, M. G., Velasco, S., Bayés-Genís, A., López, A., Muñoz-Aguilera, R., de Teresa, E., González-Juanatey, J. R., Evangelista, A., Mombiela, T., González-Mansilla, A., Elízaga, J., Martín-Moreiras, J., González-Santos, J. M., Moreno-Escobar, E., Fernández-Avilés, F., Sildenafil for Improving Outcomes after VAlvular Correction (SIOVAC) investigators, Bermejo, J., Yotti, R., Mombiela, T., Gónzález-Mansilla, A., Elízaga, J., García-Robles, J. A., Pérez-David, E., Pérez del Villar, C., Sanz, R., Gutierrez-Ibanes, E., Vázquez, M. E., Mur, A., Benito, Y., Martínez-Legazpi, P., Barrio, A., Vázquez, A., García-Orta, R., Uribe, I., González, M., Luis Sánchez, P., González-Santos, J. M., Martín-Moreiras, J., Arribas, A., Clemente Lorenzo, M. M., Diego Nieto, A., Castaño, M., Pérez de Prado, A., Alonso, D., Segovia-Cubero, J., Gómez-Bueno, M., Sayago Silva, I., Ángel Cavero, M., Escribano-Subias, P., Domínguez, L., Tello de Meneses, R., Ruiz Cano, M. J., Jiménez López-Guarch, C., San Román, J. A., Mota, P., Borrás, X., Amorós Galitó, C., Alonso-Gómez, A., Belló Mora, M. C., Mesa Rubio, D., Botas, J., Campuzano, R., Crespo-Leiro, M. G., Marzoa, R., Cuenca, J., Velasco, S., Muñoz, R., Suberviola, V., Beltrán Herrera, C., Mora, L., Mar Sarrión, M., Vaqueriza, D., Bayes-Genís, A., Ferrer, E., González-Juanatey, J. R., Cid, B., Monzonís, A. M., López, A., Arizón de Prado, J. M., Santisteban, M., Mesa Rubio, D., Evangelista, A., García-Dorado, D., de Teresa, E., Jiménez-Navarro, M., Carrasco Chinchilla, F., Moreno-Escobar, E., & Alonso, J.
Venue
European Heart Journal
Published
2017-12-21
Volume
39
Issue
15
Pages
1255-1264
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2806263607
Cited by
230
References
2
FWCI
16.81
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehx700
The paper
Bermejo, J., Yotti, R., García-Orta, R., Sánchez-Fernández, P. L., Castaño, M., Segovia-Cubero, J., Escribano-Subías, P., San Román, J. A., Borrás, X., Alonso-Gómez, A., Botas, J., Crespo-Leiro, M. G., Velasco, S., Bayés-Genís, A., López, A., Muñoz-Aguilera, R., de Teresa, E., González-Juanatey, J. R., Evangelista, A., . . . Alonso, J. (2018). Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehx700

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.